C&EN Stem Cell Archive
April 16, 2007
Senate Clears Stem Cell Bill
Congress moves to expand embryonic stem cell policy.
April 9, 2007
Stem Cell Patents Under Fire
Patent & Trademark Office invalidates three key embryonic stem cell patents.
March 26, 2007
Stem Cells
NIH director calls for expanded federal policy.
February 28, 2007
Court Upholds Stem Cell Initiative
Appeals court deems $3 billion California stem cell program to be constitutional.
January 24, 2007
Stem Cell Patent Enforcement Eased
Patent holder announces policy changes and clarifications to facilitate research.
January 15, 2007
Taming Stem Cells
Researchers are defining the chemical preferences of stem cells and figuring out what keeps them eternal and what destines them to a differentiated fate.
Reducing Animal Testing Using Stem Cells
Stem cells may provide a complementary alternative to animals as in vitro models of disease and for toxicological testing.
Claims Under Fire
The future of embryonic stem cell research in the U.S. may hinge on the current review of key patents.
Rolling Out Stem Cells
Industry aims to capitalize on the promise of these potent cells.
Getting To The Root Of Cancer
The dark side of stem cells is initiating a revolution in cancer research.
Congress Targets Expanded Federal Policy
Progress On Stem Cells
John Scott Award Goes to Davis and Weissman
September 18, 2006
Rough Ride For Stem Cell Research
Embryonic stem cell scientists are on roller coaster of funding, research highs and lows.
July 24, 2006
Of Mice And Men
Bush Nixes Stem Cell Research Bill
Congress passes bill to expand federal stem cell policy; President quickly vetoes it.
July 19, 2006
Bush Vetoes Stem Cell Bill
Legislation to expand the federal stem cell research policy is rejected.
Stem Cell Research Bill Clears Senate
Genes would be hardly more than molecular dead weight if not for the 'epigenetic' context that turns them on and off.
July 17, 2006
Pulling Genes' Strings
Chemistry professor weaves together science and society on his weekly radio gig.
August 2, 2005
Stem Cell Bill Gets Boost From Sen. Bill Frist
Senate Majority Leader breaks with White House on expanding embryonic stem cell research.
July 25, 2005
The Ethics Of Stem Cell Research
Senate hearing probes potential alternatives to embryos as embryonic stem cell source.
June 13, 2005
Stem Cell Research
May 30, 2005
Expanding Stem Cell Research
House passes bill to fund expansion of human embryonic stem cell research.
May 2, 2005
Ethical Stem Cell Research
Academies provide guidance for work largely unregulated by federal government.
February 14, 2005
Stem Cell Chemistry
Chemists and engineers offer help in identifying molecules that direct stem cell behavior.
March 28, 2005
States And Stem Cells
Growing role of states in funding embryonic stem cell research can challenge researchers.
November 22, 2004
Stem Cell Talk
Briefing highlights need for public awareness to gain support for research.
November 1, 2004
Human Embryonic Stem Cell Debate
National Academies committee meets to develop guidelines for emerging and controversial field.
July 19, 2004
Stem Cell Research
Amid calls for an expansion of the federal policy, Administration upholds embryonic research limits.
June 28, 2004
Expanding Stem Cell Research
Bill would allow federal funds for work on lines derived after Aug. 9, 2001.
May 24, 2004
Zerhouni On Stem Cells
NIH director defends Bush policy on stem cell research to Congress.
October 20, 2003
Embryonic Stem Cells' Support
Polymer scaffold provides surface for three-dimensional tissue growth.
May 12, 2003
Stem Cell Standards
Proposal for characterizing cell lines may touch off wider debate.
March 11, 2002
Canada Issues Stem Cell Rules
Research guidelines may prompt U.S. researchers to work abroad.
September 17, 2001
Stem Cell Facts Laid Out
National Academies report attempts to define what's real and what's not.
September 3, 2001
Stem Cell Line Counts Questioned
But scientists say U.S. basic research effort can now move forward.
August 27, 2001
Stem Cell Angst
Patent and licensing issues gum up stem cell development.
August 20, 2001
Qualified Praise For Stem Cell Decision
Scientists see narrow research agenda, given Bush Administration restrictions.
July 16, 2001
Embryo Stem Cells And Research
The National Academies workshop probes ethics, implications of ban on federal funding.
August 28, 2000
NIH Finalizes Stem Cell Research Rules
December 6, 1999
NIH Sets Guidelines For Stem Cell Research
December 8, 2003
Kennett Burnes
Cabot Corp. CEO appreciates 19th-century amenities but has a 21st-century sensibility.
November 24, 2003
Una S. Ryan
Avant Immunotherapeutics head offers model for philanthropy by preprofitable companies.
October 6, 2003
Werner Mueller
Chemist draws on a career in industry now that he's on his own in the lab.
July 14, 2003
Rudolf Hanko
Bayer's head of fine chemicals puts technology in a service context.
May 19, 2003
James P. Trevelyan
A mechanical engineer addresses the practical challenges of humanitarian demining.
April 28, 2003
Neville Reed
Royal Society of Chemistry general manager explains why the society is broadening its base.
April 21, 2003
Charles E. Mcqueary
The Department of Homeland Security's undersecretary for science and technology is the go-to man if you have a way to counter terrorism.
February 24, 2003
Stephanie Burns
Science has always been the key to success for Dow Corning's new chief operating officer.
December 9, 2002
Victoria Bragin
Van Cliburn Award winner and science educator balances excellence in piano and chemistry.
October 28, 2002
Paul Wennberg
MacArthur Foundation's latest award winner grapples with the planet's atmospheric health.
September 30, 2002
An Undergraduate Champion
University of Arizona's Mike Doyle wants more undergraduates to do chemistry research.
September 23, 2002
Harold Sorgenti
Entrepreneur and former Arco president says the time is right to invest in chemicals.
August 5, 2002
Peter Nagler
Degussa Fine Chemicals head is optimistic that innovation will overcome excess capacity.
May 6, 2002
Yusuf S. Hamied
Cipla's Yusuf S. Hamied turns conventional wisdom on pharmaceutical patents upside down.
April 29, 2002
Robert Wood
Head of Dow's thermosets business discusses his unique background, business philosophy.
February 4, 2002
Jon Huntsman
Huntsman Corp. chairman reflects on the financial fix he's in and how he'll get out of it.
December 24, 2001
Clemens Roothaan
Seasoned theoretician reflects on a half century of quantum chemistry advances.
December 17, 2001
Robert H. Black
Former high school teacher formulates chemical solutions to other people's problems.
November 26, 2001
Thomas Waltermire
President and CEO of PolyOne discusses metamorphosis of his compounding company.
August 6, 2001
Gordon Cain
Leveraged buyout titan, now a venture capitalist, issues second edition of his autobiography.
August 6, 2001
Ruth L. Kirschstein
Career NIH researcher steers health agency through interesting times for federal R&D.
July 30, 2001
Helge Wehmeier
American Chemistry Council's Long-Range Research Initiative chooses areas where it can make an impact.
March 5, 2001
Andrew Liveris
The president of Dow's performance chemicals business discusses his new product strategy.
